Its antioxidant and free radical-quenching properties have been shown to promote neurological wellbeing and its demonstrated ability to modulate glutamate in the brain are thought to contribute to better mood stability
However, routine high-dose supplementation is not recommended without documented deficiencies
For combination therapy BSO (1 mM) was added to the cells 8 h before every paracetamol concentration (1, 1.25, 1.5, 1.75, and 2 mM)
These include mutations in genes such as: SNCA Alpha-synuclein gene PRKN Parkin RBR E3 Ubiquitin Protein Ligase PINK1 Gene PARK6 DJ-1 and PARK7 Gene LRRK2 It is believed that mutations in these genes can cause dysfunction and eventual death of dopamine-producing neurons through various mechanisms, including protein aggregation, mitochondrial dysfunction, and oxidative stress
This is the most cost-effective strategy and what we typically recommend as the foundation of a glutathione tirzepatide stack